Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
FEMALE
ID07065214

Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy: A Prospective Controlled Randomized Pilot Study

Led by Erbe Elektromedizin GmbH · Updated on 2025-11-28

72

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating two surgical methods for treating ovarian endometrioma in women to understand how each method affects ovarian reserve. This pilot study compares the standard cystectomy procedure with argon plasma coagulation (APC) treatment by monitoring changes in serum Anti-Müller hormone (AMH) levels after surgery. The study is conducted as a prospective, randomized controlled trial at the Department for Women's Health in Tuebingen, Germany. Participants will be randomly assigned to one of two groups: one receiving the standard cystectomy using lap bipolar forceps, and the other undergoing APC treatment with a CE-approved APC applicator device. The surgical treatment will be performed during the second visit. Follow-up visits are scheduled at three, six, and twelve months after the procedure, with AMH levels measured during the three- and six-month visits. The twelve-month follow-up will be conducted through a phone call. Women who qualify will participate in five visits: screening, treatment, and three follow-ups. Screening occurs first to confirm eligibility. Blood tests to measure AMH levels will be done at the study site during follow-up visits three and four. The final follow-up will be remote via telemedicine. Safety and treatment effects will be assessed throughout, with the main outcome focused on changes in AMH concentration up to six months post-treatment.

CONDITIONS

Brief Title

Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy

Who Can Participate

Age: 18Years - 40Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Indication for surgical endometrioma treatment according to patient symptoms
  • Signed informed consent
  • Female aged between 18 and 40 years
Not Eligible

You will not qualify if you...

  • Expected lack of compliance or inability to understand the clinical trial purpose
  • Prior procedures at the ovaries
  • Recurrent ovarian endometrioma
  • Pregnant or breastfeeding patients
  • Participation in any other clinical study that could affect AMH level or pregnancy status
  • Male gender
  • Age below 18 or above 40 years old
  • Patients with recurrent endometriosis outside the ovaries only (allowed if no ovarian recurrence)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Up to 1 day

Participants undergo surgical treatment of ovarian endometrioma using either standard cystectomy or argon plasma coagulation (APC) applicator.

1 surgery visit (in-person)

Post-operative Follow-up

Duration - 6 months

Participants have follow-up visits to monitor recovery and assess Anti-Müller hormone (AMH) levels after surgery.

2 visits (at 3 months and 6 months post-surgery, in-person)

Trial Site Locations

Total: 1 location

1

Department for Women's Health

Tübingen, Germany, Germany, 72076

Actively Recruiting

Loading map...

Research Team

V

Vanessa Steinmetz

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Phase 2, Randomized, Double-blind, Placebo-controlled Tria...

Endometriosis

Actively Recruiting

41 locations

A Phase 3B, Single-Arm Study to Evaluate Bone Mineral Densit...

Uterine Fibroids

Actively Recruiting

120 locations

A Randomized Controlled Trial of a Nutritional Intervention ...

Endometriosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Endometrioma surgery-a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone.

Johnny S Younis, Nora Shapso, Yval Ben-Sira...

https://pubmed.ncbi.nlm.nih.gov/34265271

Microscopic, Macroscopic and Thermal Impact of Argon Plasma, Diode Laser, and Electrocoagulation on Ovarian Tissue.

Stefan Stefanovic, Marc Sütterlin, Timo Gaiser...

https://pubmed.ncbi.nlm.nih.gov/36881055

Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence.

E K Lockyer, Amf Schreurs, McI Lier...

https://pubmed.ncbi.nlm.nih.gov/31695857

Recommendations for the surgical treatment of endometriosis-part 1: ovarian endometrioma.

Working group of ESGE, ESHRE, and WES, Ertan Saridogan, Christian M Becker...

https://pubmed.ncbi.nlm.nih.gov/29285022

Comparison between the stripping technique and the combined excisional/ablative technique for the treatment of bilateral ovarian endometriomas: a multicentre RCT.

Ludovico Muzii, Chiara Achilli, Valentino Bergamini...

https://pubmed.ncbi.nlm.nih.gov/26682578